Navigation Links
InVitria Reveals Technology to Optimize Hybridoma Production Performance
Date:4/27/2009

Fort Collins, CO April 27, 2009 / b3c newswire / – Recent studies using both classical media and the leading commercial serum-free hybridoma media formulations proved that InVitria’s cell culture supplements optimized cell growth and productivity of hybridoma cells. 1 Further, the studies revealed that Cellastim supports cell adaptation and survival in chemically-defined media.

Additional findings from the study showed that Cellastim improved the cell growth and productivity in long-term culture. In a 25-day period, cell doublings in Cellastim-supplemented media were twice that of media without Cellastim. Also, antibody production was 65% higher in the commercial media with Cellastim while cells supplemented with Cellastim grew to higher density than those in unsupplemented media.

“This research incorporated classical media as well as several leading commercial media available on the market,” said Dr. Steve Pettit, the project’s lead researcher. “We achieved optimal cell density and quicker doubling times as well as better cell productivity when Cellastim was added to these media. We also reported that Lacromin improves hybridoma cell culture performance.”

Lacromin increased cell density in supplemented media nearly double compared to that of media without Lacromin supplementation. A significant increase in antibody production was recognized in all Lacromin-treated media, exceeding the level achieved with 5% fetal bovine serum (FBS).

 “This research supports what customers have been reporting from their use of Cellastim and Lacromin for hybridoma cell culture,” said InVitria President and CEO Scott Deeter. “Cellastim has been shown to not only optimize hybridoma performance, but also outperform other sources of native and recombinant albumin.”

To obtain a copy of the above-mentioned article entitled, “Enhanced Growth and Productivity of a Hybridoma with Recombinant Human Albumin and Lactoferrin,” please contact InVitria at info@InVitria.com or 1-800-916-8311.


About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research and diagnostics.


Contact

Erik H. Vogel
InVitria
Marketing Manager
Phone: 1-800-916-8311
www.InVitria.com

----------------------------------------------------------------------------------
1 Pettit S, Santos M, Tanner T, Huang N. Enhanced Growth and Productivity of a Hybridoma with Recombinant Human Albumin and Lactoferrin. BioProcessing Journal 2009; 8(1): 50-55. 


'/>"/>
b3c newswire

Related biology technology :

1. InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication
2. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
3. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
4. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
5. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
6. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
7. InVitria Expands Sales Team
8. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
9. Proteomics Study Reveals That Genes Involved in Invertebrate Longevity Have Surprising Parallels in Humans.
10. New imaging technique reveals the atomic structure of nanocrystals
11. Mouse study reveals genetic component of empathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
Breaking Biology Technology:
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):